Skip to content


Nplate (romiplostim) is a protein pharmaceutical. Romiplostim was first approved as Nplate on 2008-08-22. It is used to treat thrombocytopenic purpura idiopathic in the USA. It has been approved in Europe to treat thrombocytopenic purpura idiopathic. The pharmaceutical is active against thrombopoietin receptor.
Trade Name Nplate
Common Name Romiplostim
Indication thrombocytopenic purpura idiopathic
Drug Class Colony-stimulating factors
Get full access now